Yi‐An Bi

2.1k total citations
40 papers, 1.7k citations indexed

About

Yi‐An Bi is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yi‐An Bi has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 19 papers in Pharmacology and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yi‐An Bi's work include Drug Transport and Resistance Mechanisms (33 papers), Pharmacological Effects and Toxicity Studies (16 papers) and Pharmacogenetics and Drug Metabolism (15 papers). Yi‐An Bi is often cited by papers focused on Drug Transport and Resistance Mechanisms (33 papers), Pharmacological Effects and Toxicity Studies (16 papers) and Pharmacogenetics and Drug Metabolism (15 papers). Yi‐An Bi collaborates with scholars based in United States, Japan and Australia. Yi‐An Bi's co-authors include Manthena V. S. Varma, Emi Kimoto, David B. Duignan, Yurong Lai, Jian Lin, Larry M. Tremaine, Sumathy Mathialagan, Chester Costales, A. David Rodrigues and Ayman El‐Kattan and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

Yi‐An Bi

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi‐An Bi United States	27	1.2k	964	554	234	165	40	1.7k
Katherine S. Fenner United Kingdom	20	1.0k 0.9×	619 0.6×	483 0.9×	337 1.4×	152 0.9×	28	1.7k
Kathryn E. Kenworthy United Kingdom	15	1.0k 0.9×	771 0.8×	557 1.0×	302 1.3×	149 0.9×	16	1.6k
A. David Rodrigues United States	26	772 0.7×	924 1.0×	328 0.6×	416 1.8×	143 0.9×	49	1.8k
Matthew G. Soars United States	20	785 0.7×	979 1.0×	288 0.5×	378 1.6×	103 0.6×	32	1.6k
Robert Elsby United Kingdom	20	729 0.6×	551 0.6×	363 0.7×	367 1.6×	109 0.7×	25	1.6k
A. David Rodrigues United States	31	1.3k 1.1×	1.1k 1.2×	647 1.2×	444 1.9×	194 1.2×	73	2.5k
K Rowland‐Yeo United Kingdom	16	519 0.4×	702 0.7×	327 0.6×	285 1.2×	163 1.0×	22	1.6k
Mitchell E. Taub United States	19	908 0.8×	390 0.4×	464 0.8×	354 1.5×	109 0.7×	51	1.4k
Mingxiang Liao United States	19	715 0.6×	533 0.6×	315 0.6×	309 1.3×	172 1.0×	46	1.2k
David Hallifax United Kingdom	21	809 0.7×	1.2k 1.2×	233 0.4×	349 1.5×	122 0.7×	31	1.8k

Countries citing papers authored by Yi‐An Bi

Since Specialization

Citations

This map shows the geographic impact of Yi‐An Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐An Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐An Bi more than expected).

Fields of papers citing papers by Yi‐An Bi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐An Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐An Bi. The network helps show where Yi‐An Bi may publish in the future.

Co-authorship network of co-authors of Yi‐An Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐An Bi. A scholar is included among the top collaborators of Yi‐An Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐An Bi. Yi‐An Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bi, Yi‐An, et al.. (2024). Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay. Clinical Pharmacology & Therapeutics. 115(6). 1336–1345. 5 indexed citations

Bi, Yi‐An, Amanda King‐Ahmad, Mark A. West, et al.. (2024). Low Molecular Weight Acids and Organic Anion Transporting Polypeptide (OATP1B)-Mediated Hepatic Clearance: In Vitro and In Vivo Evaluation Using Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (Dustats). Drug Metabolism and Disposition. 52(5). 399–407. 1 indexed citations

Weng, Yan, Kari R. Fonseca, Yi‐An Bi, et al.. (2022). Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, a First-In-Class Ketohexokinase Inhibitor for Metabolic Disorders and Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 50(9). 1312–1321. 6 indexed citations

Eng, Heather, Yi‐An Bi, Mark A. West, et al.. (2021). Organic Anion–Transporting Polypeptide 1B1/1B3–Mediated Hepatic Uptake Determines the Pharmacokinetics of Large Lipophilic Acids: In Vitro–In Vivo Evaluation in Cynomolgus Monkey. Journal of Pharmacology and Experimental Therapeutics. 377(1). 169–180. 15 indexed citations

Mathialagan, Sumathy, Yi‐An Bi, Chester Costales, et al.. (2020). Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7). Biochemical Pharmacology. 174. 113829–113829. 31 indexed citations

Bi, Yi‐An, Chester Costales, Sumathy Mathialagan, et al.. (2019). Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 370(1). 72–83. 66 indexed citations

Bi, Yi‐An, Sumathy Mathialagan, Laurie Tylaska, et al.. (2018). Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug. Journal of Pharmacology and Experimental Therapeutics. 364(3). 390–398. 32 indexed citations

Bi, Yi‐An, Renato J. Scialis, Sarah Lazzaro, et al.. (2017). Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. The AAPS Journal. 19(3). 787–796. 39 indexed citations

Li, Rui, Yi‐An Bi, Anna Vildhede, et al.. (2017). Transporter-Mediated Disposition, Clinical Pharmacokinetics and Cholestatic Potential of Glyburide and Its Primary Active Metabolites. Drug Metabolism and Disposition. 45(7). 737–747. 10 indexed citations

10.

Varma, Manthena V. S., Renato J. Scialis, Jian Lin, et al.. (2014). Mechanism-Based Pharmacokinetic Modeling to Evaluate Transporter-Enzyme Interplay in Drug Interactions and Pharmacogenetics of Glyburide. The AAPS Journal. 16(4). 736–748. 45 indexed citations

11.

Varma, Manthena V. S., Jian Lin, Yi‐An Bi, et al.. (2013). Quantitative Prediction of Repaglinide-Rifampicin Complex Drug Interactions Using Dynamic and Static Mechanistic Models: Delineating Differential CYP3A4 Induction and OATP1B1 Inhibition Potential of Rifampicin. Drug Metabolism and Disposition. 41(5). 966–974. 47 indexed citations

12.

Di, Li, Patrick Trapa, R. Scott Obach, et al.. (2012). A Novel Relay Method for Determining Low-Clearance Values. Drug Metabolism and Disposition. 40(9). 1860–1865. 78 indexed citations

13.

Di, Li, Christopher Keefer, Dennis O. Scott, et al.. (2012). Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. European Journal of Medicinal Chemistry. 57. 441–448. 98 indexed citations

14.

Bi, Yi‐An, Emi Kimoto, Hannah M. Jones, et al.. (2012). In Vitro Evaluation of Hepatic Transporter-Mediated Clinical Drug-Drug Interactions: Hepatocyte Model Optimization and Retrospective Investigation. Drug Metabolism and Disposition. 40(6). 1085–1092. 52 indexed citations

15.

Kotani, Naoki, Kazuya Maeda, Takao Watanabe, et al.. (2011). Culture Period-Dependent Changes in the Uptake of Transporter Substrates in Sandwich-Cultured Rat and Human Hepatocytes. Drug Metabolism and Disposition. 39(9). 1503–1510. 60 indexed citations

16.

Kimoto, Emi, Robert L. Walsky, Hui Zhang, et al.. (2011). Differential Modulation of Cytochrome P450 Activity and the Effect of 1-Aminobenzotriazole on Hepatic Transport in Sandwich-Cultured Human Hepatocytes. Drug Metabolism and Disposition. 40(2). 407–411. 35 indexed citations

17.

Kimoto, Emi, et al.. (2010). Characterization of Digoxin Uptake in Sandwich-Cultured Human Hepatocytes. Drug Metabolism and Disposition. 39(1). 47–53. 38 indexed citations

18.

Feng, Bo, Jinghai J. Xu, Yi‐An Bi, et al.. (2009). Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714. Toxicological Sciences. 108(2). 492–500. 56 indexed citations

19.

Cashman, John R., Yi‐An Bi, Jing Lin, et al.. (1997). Human Flavin-Containing Monooxygenase Form 3: cDNA Expression of the Enzymes Containing Amino Acid Substitutions Observed in Individuals with Trimethylaminuria. Chemical Research in Toxicology. 10(8). 837–841. 47 indexed citations

20.

Bi, Yi‐An & Howard M. Laten. (1996). Sequence analysis of a cDNA containing the gag and prot regions of the soybean retrovirus-like element, SIRE-1. Plant Molecular Biology. 30(6). 1315–1319. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact